Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.

Spector SA, Qin M, Lujan-Zilbermann J, Singh KK, Warshaw MG, Williams PL, Jean-Philippe P, Fenton T, Siberry GK; IMPAACT P1065 Protocol Team.

Clin Vaccine Immunol. 2013 Jun;20(6):900-6. doi: 10.1128/CVI.00042-13. Epub 2013 Apr 17.


Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.

Siberry GK, Warshaw MG, Williams PL, Spector SA, Decker MD, Jean-Philippe P, Yogev R, Heckman BE, Manzella A, Roa J, Nachman S, Lujan-Zilbermann J; IMPAACT P1065 Protocol Team.

Pediatr Infect Dis J. 2012 Jan;31(1):47-52. doi: 10.1097/INF.0b013e318236c67b.


Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.

Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S; IMPAACT P1065 Protocol Team.

Pediatr Infect Dis J. 2010 May;29(5):391-6. doi: 10.1097/INF.0b013e3181c38f3b.


Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.

Lujan-Zilbermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heckman B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, Siberry GK; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1065 Protocol Team.

J Pediatr. 2012 Oct;161(4):676-81.e2. doi: 10.1016/j.jpeds.2012.04.005. Epub 2012 May 22.


Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Pine SO, McElrath MJ, Bochud PY.

AIDS. 2009 Nov 27;23(18):2387-95. doi: 10.1097/QAD.0b013e328330b489.


Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.

Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35. doi: 10.1097/QAI.0b013e318184fb41.


Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.

Moore CE, Hennig BJ, Perrett KP, Hoe JC, Lee SJ, Fletcher H, Brocklebank D, O'Connor D, Snape MD, Hall AJ, Segal S, Hill AV, Pollard AJ.

Clin Vaccine Immunol. 2012 Mar;19(3):295-303. doi: 10.1128/CVI.05379-11. Epub 2011 Dec 28.


Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.

Bröker M, Veitch K.

Travel Med Infect Dis. 2010 Jan;8(1):47-50. doi: 10.1016/j.tmaid.2009.12.001. Epub 2010 Jan 8.


Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.

Sakou II, Tzanakaki G, Tsolia MN, Sioumala M, Barbouni A, Kyprianou M, Papaevangelou V, Tsitsika A, Blackwell CC, Kafetzis D, Kremastinou J.

Vaccine. 2009 Jul 16;27(33):4408-11. doi: 10.1016/j.vaccine.2009.05.047. Epub 2009 Jun 3.


TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.

Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW.

J Gastroenterol Hepatol. 2007 Nov;22(11):1760-6.


Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.

Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Oster P, Borrow R.

Vaccine. 2014 Sep 29;32(43):5715-21. doi: 10.1016/j.vaccine.2014.08.026. Epub 2014 Aug 20.


Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.

Royse KE, Kempf MC, McGwin G Jr, Wilson CM, Tang J, Shrestha S.

J Reprod Immunol. 2012 Dec;96(1-2):84-9. doi: 10.1016/j.jri.2012.08.002. Epub 2012 Sep 28.


The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.

Rybka J, Butrym A, Wróbel T, Jaźwiec B, Stefanko E, Dobrzyńska O, Poręba R, Kuliczkowski K.

Leuk Res. 2015 Mar;39(3):318-22. doi: 10.1016/j.leukres.2015.01.002. Epub 2015 Jan 13.


Role of polymorphisms of toll-like receptor (TLR) 4, TLR9, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children.

Esposito S, Molteni CG, Zampiero A, Baggi E, Lavizzari A, Semino M, Daleno C, Groppo M, Scala A, Terranova L, Miozzo M, Pelucchi C, Principi N.

Malar J. 2012 Jun 12;11:196. doi: 10.1186/1475-2875-11-196.


Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis.

van Well GT, Sanders MS, Ouburg S, van Furth AM, Morré SA.

PLoS One. 2012;7(5):e35837. doi: 10.1371/journal.pone.0035837. Epub 2012 May 25.


Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults.

Bertolini DV, Costa LS, van der Heijden IM, Sato HK, Marques HH.

Vaccine. 2012 Aug 10;30(37):5482-6. doi: 10.1016/j.vaccine.2012.06.069. Epub 2012 Jul 6.


Association of TLR2 gene polymorphisms with ocular Behcet's disease in a Chinese Han population.

Fang J, Hu R, Hou S, Ye Z, Xiang Q, Qi J, Zhou Y, Kijlstra A, Yang P.

Invest Ophthalmol Vis Sci. 2013 Dec 30;54(13):8384-92. doi: 10.1167/iovs.13-12878.

Items per page

Supplemental Content

Write to the Help Desk